Solid Biosciences (SLDB) announced initial data from the Phase 1/2 INSPIRE DUCHENNE trial evaluating SGT-003, a next-generation gene therapy ...
The report was largely positive, but did find there were issues with staff shortages and a lack of Māori input.
Company reported positive Phase 2b QUALITY study topline results for enobosarm + semaglutide (Wegovy®) with study meeting prespecified primary ...
AIM Vaccine Co., Ltd. (06660.HK), a leading PRC vaccine company, published an announcement on February 11, 2025, announced that its independently developed mRNA shingles vaccine has been submitted for ...
Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the "Company" or "Nexalin") the leader in Deep Intracranial Frequency Stimulation (DIFS) of the brain, announces ...
I’m exhausted.” Chances are, you’ve already said this today or caught someone else inserting it into a conversation. There are plenty of reasons you could be feeling more drained than usual. You might ...
A panel of 14 medical experts say that no babies were murdered in Lucy Letby's care. They have come together to publish what ...
One lawsuit accuses the DOJ of compiling retaliation lists. Another claims the CDC and other agencies deleted medical data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results